These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 1518958)
21. Effects of endogenous and exogenous lysophosphatidylcholine in isolated perfused rat hearts. Sargent CA; Vesterqvist O; Ogletree ML; Grover GJ J Mol Cell Cardiol; 1993 Aug; 25(8):905-13. PubMed ID: 8263961 [TBL] [Abstract][Full Text] [Related]
22. Acute administration of epirubicin induces myocardial depression in isolated rat heart and production of radical species evaluated by electron spin resonance spectroscopy. Delemasure S; Sicard P; Lauzier B; Moreau D; Vergely C; Rochette L J Cardiovasc Pharmacol; 2007 Dec; 50(6):647-53. PubMed ID: 18091581 [TBL] [Abstract][Full Text] [Related]
23. Inhibition of beta- but not alpha 1-mediated adrenergic responses in isolated hearts and cardiomyocytes by nitric oxide and 8-bromo cyclic GMP. Ebihara Y; Karmazyn M Cardiovasc Res; 1996 Sep; 32(3):622-9. PubMed ID: 8881523 [TBL] [Abstract][Full Text] [Related]
24. Inhibition of iNOS protects the aging heart against beta-adrenergic receptor stimulation-induced cardiac dysfunction and myocardial ischemic injury. Li D; Qu Y; Tao L; Liu H; Hu A; Gao F; Sharifi-Azad S; Grunwald Z; Ma XL; Sun JZ J Surg Res; 2006 Mar; 131(1):64-72. PubMed ID: 16154595 [TBL] [Abstract][Full Text] [Related]
25. Treatment with atorvastatin partially protects the rat heart from harmful catecholamine effects. Schmechel A; Grimm M; El-Armouche A; Höppner G; Schwoerer AP; Ehmke H; Eschenhagen T Cardiovasc Res; 2009 Apr; 82(1):100-6. PubMed ID: 19136528 [TBL] [Abstract][Full Text] [Related]
26. Impairment of the extraneuronal O-methylating system of isoproterenol by stop-flow ischemia in the perfused rat heart. Inoue M; Hifumi K; Kurahashi K; Fujiwara M J Pharmacol Exp Ther; 1987 Sep; 242(3):1086-9. PubMed ID: 3656108 [TBL] [Abstract][Full Text] [Related]
27. Carbon monoxide exposure in rat heart: evidence for two modes of toxicity. Patel AP; Moody AJ; Sneyd JR; Handy RD Biochem Biophys Res Commun; 2004 Aug; 321(1):241-6. PubMed ID: 15358241 [TBL] [Abstract][Full Text] [Related]
28. The role of Akt and mitogen-activated protein kinase systems in the protective effect of poly(ADP-ribose) polymerase inhibition in Langendorff perfused and in isoproterenol-damaged rat hearts. Pálfi A; Tóth A; Kulcsár G; Hantó K; Deres P; Bartha E; Halmosi R; Szabados E; Czopf L; Kálai T; Hideg K; Sümegi B; Tóth K J Pharmacol Exp Ther; 2005 Oct; 315(1):273-82. PubMed ID: 15951400 [TBL] [Abstract][Full Text] [Related]
29. Antioxidant effects of a Rhodobryum roseum extract and its active components in isoproterenol-induced myocardial injury in rats and cardiac myocytes against oxidative stress-triggered damage. Hu Y; Guo DH; Liu P; Rahman K; Wang DX; Wang B Pharmazie; 2009 Jan; 64(1):53-7. PubMed ID: 19216232 [TBL] [Abstract][Full Text] [Related]
30. Preventive effect of S-allylcysteine on lipid peroxides and antioxidants in normal and isoproterenol-induced cardiotoxicity in rats: a histopathological study. Padmanabhan M; Prince PS Toxicology; 2006 Jul; 224(1-2):128-37. PubMed ID: 16757080 [TBL] [Abstract][Full Text] [Related]
31. The effect of amrinone on LDH release and perfusion pressure in isolated ischemic rabbit hearts. Löwe H; Schulz U; Blasig IE Pharmazie; 1988 Jul; 43(7):501-2. PubMed ID: 3222285 [TBL] [Abstract][Full Text] [Related]
32. Persistent desensitization of the heart to the inotropic action of isoproterenol by adenosine. Newman WH; Lee JT; Webb JG Res Commun Chem Pathol Pharmacol; 1989 Nov; 66(2):233-54. PubMed ID: 2602656 [TBL] [Abstract][Full Text] [Related]
33. Influence of phenytoin on isoproterenol-induced myocardial fibrosis in rats. Besbasi FS; Hamlin RL Am J Vet Res; 1990 Jan; 51(1):36-9. PubMed ID: 2301818 [TBL] [Abstract][Full Text] [Related]
34. Myocardial lesions induced by natural catecholamines in vitro. Mosinger B; Stejskal J; Tutterová M; Vavrínková H Eur J Cardiol; 1978 Jan; 6(5):389-402. PubMed ID: 624319 [TBL] [Abstract][Full Text] [Related]
35. Prevention by L(-) ascorbic acid of isoproterenol-induced cardiotoxicity in primary cultures of rat myocytes. Ramos K; Acosta D Toxicology; 1983 Jan; 26(1):81-90. PubMed ID: 6829032 [TBL] [Abstract][Full Text] [Related]
36. Perturbation of the sarcolemmal membrane in isoproterenol-induced myocardial injury of the rat. Permeability and freeze-fracture studies in vivo and in vitro. Yunge L; Bruneval P; Cokay MS; Berry B; Peters H; Poulsen R; Hüttner I Am J Pathol; 1989 Jan; 134(1):171-85. PubMed ID: 2913824 [TBL] [Abstract][Full Text] [Related]
37. Cardiotoxic effects of the combined use of caffeine and isoproterenol in the minipig. Vick J; Joseph X; Whitehurst V; Herman E; Balazs T J Toxicol Environ Health; 1989; 26(4):425-35. PubMed ID: 2709437 [TBL] [Abstract][Full Text] [Related]
38. Lipolysis is an important determinant of isoproterenol-induced myocardial necrosis. Mohan P; Bloom S Cardiovasc Pathol; 1999; 8(5):255-61. PubMed ID: 10533957 [TBL] [Abstract][Full Text] [Related]
39. [The effect of calcium antagonists on the cardiotoxic effects of isoprenaline in rats]. Ljubuncić P; Stojiljković MP; Winterhalter-Jadrić M; Mujić F; Vidović Z Vojnosanit Pregl; 1992; 49(4):305-11. PubMed ID: 1481442 [TBL] [Abstract][Full Text] [Related]
40. Effect of a novel tetrapeptide derivative in a model of isoproterenol induced myocardial necrosis. Ramesh CV; Malarvannan P; Jayakumar R; Jayasundar S; Puvanakrishnan R Mol Cell Biochem; 1998 Oct; 187(1-2):173-82. PubMed ID: 9788755 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]